Economy
Moody's rates Malaysia's plan to shrink budget deficit as credit positive
Moody's rates Malaysia's plan to shrink budget deficit as credit positive
In line with 2020 book-balancing targets.
India's diesel deregulation can lower government's subsidy bill by 0.3-0.4% GDP
The move has clear economic benefits.
Value of China's hotel investments and transactions surge 16.3% QoQ
For a total value of US$121.9 million.
Unexpectedly weaker September TSF in China reaches RMB 1.05tn
Due to weaker non-bank activity.
China changes basis of resources tax
From volume based to value based.
Investors treading on thin ice amidst Occupy Central recovery
What is the ‘new normal’ going forward?.
Here's how Hong Kong developers were hurt by the Occupy Central protest
And are REITs badly hurt?.
Easing of food inflation drives decline in India's inflation rate
Fuel made a hefty contribution, too.
India's CPI inflation slows to 6.5% YoY in September
Thanks to favourable base effects.
India's weak industrial production in August signals manufacturing malaise
Government action is needed to cement recovery.
China's economic strategy has yet to do an about-face: Fitch
This follows a recent State Council statement.
Malaysia's fiscal budget may narrow to 3.0% of GDP in 2015
As part of 2020 budget targets.
Even with pressures for ASEAN integration, not everyone's in favor
But challenges may push region further together.
ASEAN integration pressures are abound
These involve economic and political factors.
ASEAN countries feared to fail at meeting economic goals: report
But here's quite a big catch.
India's industrial production predicted to gain traction
They're continuing to scale higher.
Ongoing protests insufficient to undermine Hong Kong's strong buffers: Moody's
Hong Kong's Aa1 rating remains.
Read Here
Advertise
Sign Up
Commentary
Hong Kong hospitality: Momentum and the new lifestyle era
Understanding Hong Kong’s new land premium policy
Hong Kong: At the forefront of digitalisation and evolving international disputes
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings